Estrella Immunopharma, Inc.

8-K Shareholder vote results Jun 30, 2026 10-Q Quarter ended 2026-03-31 May 18, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Delisting notice or listing-rule failure Jan 13, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 6, 2026 8-K Other events Dec 4, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Other events Nov 6, 2025 8-K Other events Sep 29, 2025 8-K Director or officer change Sep 26, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Delisting notice or listing-rule failure Aug 7, 2025 8-K Other events Jun 5, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 3, 2025 8-K Other events May 29, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Delisting notice or listing-rule failure May 2, 2025 8-K Other events Feb 21, 2025 8-K Other events Feb 20, 2025 8-K Other events Dec 16, 2024 8-K Entered a material agreement Dec 6, 2024 8-K Amended charter or bylaws Nov 26, 2024 8-K Delisting notice or listing-rule failure Nov 25, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K/A Entered a material agreement; Director or officer change Nov 7, 2024 8-K Director or officer change Nov 7, 2024 10-K/A Fiscal year ended 2024-06-30 Oct 28, 2024 10-K Fiscal year ended 2024-06-30 Sep 27, 2024 8-K Director or officer change; Regulation FD disclosure Aug 20, 2024 8-K Other events Aug 6, 2024 8-K Other events Jul 2, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Entered a material agreement May 13, 2024 8-K Regulation FD disclosure Apr 10, 2024 8-K Other events Mar 11, 2024 8-K Entered a material agreement Mar 7, 2024 10-Q Quarter ended 2023-12-31 Feb 14, 2024 8-K Changed accountants Feb 2, 2024 8-K Other events Jan 30, 2024